Electromed/ELMD

$13.94

-1.34%
-
1D1W1MYTD1YMAX

About Electromed

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

Ticker

ELMD

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

James Cunniff

Employees

170

Headquarters

New prague, United States

Electromed Metrics

BasicAdvanced
$123.92M
Market cap
32.02
P/E ratio
$0.45
EPS
0.45
Beta
-
Dividend rate
$123.92M
0.45045
$17.85
$8.80
30.76K
5.974
5.25
33.037
8.91%
10.4%
10.39%
32.018
2.397
3.071
3.119
33.922
18.03%
88.05%
13.97%
-8.27%

What the Analysts think about Electromed

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analyst.
86.51% upside
High $26.00
Low $26.00
$13.94
Current price
$26.00
Average price target

Electromed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.76% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$13.6M
10.57%
Net income
$1.6M
1,500%
Profit margin
11.76%
1,351.85%

Electromed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 90%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.12
$0.12
$0.02
$0.19
-
Expected
$0.10
$0.13
$0.10
$0.10
$0.13
Surprise
20%
-7.69%
-80%
90%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Electromed stock?

Electromed (ELMD) has a market cap of $123.92M as of April 19, 2024.

What is the P/E ratio for Electromed stock?

The price to earnings (P/E) ratio for Electromed (ELMD) stock is 32.02 as of April 19, 2024.

Does Electromed stock pay dividends?

No, Electromed (ELMD) stock does not pay dividends to its shareholders as of April 19, 2024.

When is the next Electromed dividend payment date?

Electromed (ELMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Electromed?

Electromed (ELMD) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Electromed stock price target?

The target price for Electromed (ELMD) stock is $26, which is 86.51% above the current price of $13.94. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Electromed stock

Buy or sell Electromed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing